Agenus Inc. Executive Compensation Details Revealed
Ticker: AGEN · Form: DEF 14A · Filed: Apr 30, 2025 · CIK: 1098972
Sentiment: neutral
Topics: executive-compensation, proxy-statement, equity-awards
TL;DR
Agenus Inc. DEF 14A shows exec comp details for 2020-2024, focusing on equity awards.
AI Summary
Agenus Inc. filed a DEF 14A on April 30, 2025, detailing executive compensation. The filing includes information on equity awards granted to its "PeoMember" (likely Principal Executive Officer) and "NonPeoNeoMember" (likely Non-Principal Executive Officer) for the fiscal years ending December 31, 2020, 2021, 2022, and 2024. Specific details on the fair value of these awards and vesting conditions are provided.
Why It Matters
This filing provides transparency into how Agenus Inc. compensates its top executives, which can influence investor decisions and perceptions of company management.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing providing executive compensation details, which typically carries low immediate risk.
Key Numbers
- 2020-2024 — Fiscal Years Covered (Executive compensation data spans these years.)
Key Players & Entities
- Agenus Inc. (company) — Filer of the DEF 14A
- 0000950170-25-061030 (dollar_amount) — Accession Number for the filing
- 20250430 (dollar_amount) — Filing Date
- 000-29089 (dollar_amount) — SEC File Number
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is used to solicit proxies from shareholders when the company is holding a shareholder meeting. It provides detailed information about matters to be voted on, including executive compensation, director elections, and other corporate governance issues.
Who are the 'PeoMember' and 'NonPeoNeoMember' mentioned in the filing?
While not explicitly defined in the provided text, 'PeoMember' likely refers to the Principal Executive Officer(s) and 'NonPeoNeoMember' likely refers to other Non-Principal Executive Officers of Agenus Inc., as these are common designations in SEC filings related to executive compensation.
What specific types of compensation are detailed for the executives?
The filing details information regarding equity awards, including their fair value at the end of the fiscal year, vesting conditions, and changes in fair value for awards granted in prior years.
What is the significance of the 'VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember' data point?
This data point likely represents the fair value of equity awards granted and vested during the covered year, as of their respective vesting dates, providing insight into the realized value of compensation for executives.
What is the former name of Agenus Inc. and when did the change occur?
Agenus Inc. was formerly known as ANTIGENICS INC /DE/, and the name change occurred on November 15, 1999.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 30, 2025 regarding AGENUS INC (AGEN).